BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 19736625)

  • 1. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of chaperone-mediated protein folding in the cytosol.
    Young JC; Agashe VR; Siegers K; Hartl FU
    Nat Rev Mol Cell Biol; 2004 Oct; 5(10):781-91. PubMed ID: 15459659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp70 and Hsp90--a relay team for protein folding.
    Wegele H; Müller L; Buchner J
    Rev Physiol Biochem Pharmacol; 2004; 151():1-44. PubMed ID: 14740253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of molecular chaperones in human misfolding diseases.
    Broadley SA; Hartl FU
    FEBS Lett; 2009 Aug; 583(16):2647-53. PubMed ID: 19393652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery.
    Meimaridou E; Gooljar SB; Chapple JP
    J Mol Endocrinol; 2009 Jan; 42(1):1-9. PubMed ID: 18852216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to the isolation and characterization of molecular chaperones.
    Nicoll WS; Boshoff A; Ludewig MH; Hennessy F; Jung M; Blatch GL
    Protein Expr Purif; 2006 Mar; 46(1):1-15. PubMed ID: 16199180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90: a chaperone for protein folding and gene regulation.
    Zhao R; Houry WA
    Biochem Cell Biol; 2005 Dec; 83(6):703-10. PubMed ID: 16333321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
    Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
    J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development and the cellular quality control system.
    Conn PM; Janovick JA
    Trends Pharmacol Sci; 2009 May; 30(5):228-33. PubMed ID: 19307028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperones and protein quality control.
    Bukau B; Weissman J; Horwich A
    Cell; 2006 May; 125(3):443-51. PubMed ID: 16678092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular chaperones in the cytosol: from nascent chain to folded protein.
    Hartl FU; Hayer-Hartl M
    Science; 2002 Mar; 295(5561):1852-8. PubMed ID: 11884745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive interaction of chaperones with substrate protein domains allows correct folding of the downstream GFP domain.
    Zhang A; Cantor EJ; Barshevsky T; Chong S
    Gene; 2005 Apr; 350(1):25-31. PubMed ID: 15780997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular chaperones: heat-shock proteins, foldases, and matchmakers.
    Wynn RM; Davie JR; Cox RP; Chuang DT
    J Lab Clin Med; 1994 Jul; 124(1):31-6. PubMed ID: 8035099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators.
    Henderson B
    Cell Biochem Funct; 2010 Jan; 28(1):1-14. PubMed ID: 19830685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological chaperones: a potential therapeutic treatment for conformational diseases].
    Mendre C; Mouillac B
    Med Sci (Paris); 2010; 26(6-7):627-35. PubMed ID: 20619166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress proteins and glycoproteins (Review).
    Henle KJ; Jethmalani SM; Nagle WA
    Int J Mol Med; 1998 Jan; 1(1):25-32. PubMed ID: 9852195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.